PAQ and Insilico Medicine collaborate to develop therapies through autophagy-dependent degradation Sep. 9, 2021
Researchers give rationale on the development of RAF-selective MEK inhibitors for cancer Sep. 9, 2021
Herantis advances project to combine Nanoform's technology with rhCDNF for Parkinson's disease Sep. 9, 2021
Update from large animal pilot dosing study of BB-301 for oculopharyngeal muscular dystrophy Sep. 9, 2021
ProQR and Lilly to use Axiomer RNA editing platform to target liver and nervous system disorders Sep. 9, 2021
RSS